Skip to content
Review Open access

Liver Injury Repair and Regeneration: Molecular Mechanisms and Therapeutic Targets

Nov 2026 · MedComm · Vol 7 · 0 citations · 217 references
Medicine

TL;DR

This review summarizes recent advances in liver regeneration across temporal, cellular, metabolic, and interorgan communication aspects and describes the dynamic features of different regenerative phases and emphasizes the regulatory roles of non‐parenchymal cells within the regenerative niche.

Abstract

ABSTRACT The liver possesses a remarkable regenerative capacity to restore tissue integrity and physiological function following acute injury. However, this endogenous repair potential is gradually impaired in chronic liver diseases, including metabolic dysfunction–associated steatohepatitis (MASH) and hepatic fibrosis. These disorders frequently lead to persistent inflammation and progressive hepatic dysfunction. Our incomplete understanding of the mechanisms behind pathological liver regeneration limits the development of new regenerative therapies. This review summarizes recent advances in liver regeneration across temporal, cellular, metabolic, and interorgan communication aspects. It describes the dynamic features of different regenerative phases and emphasizes the regulatory roles of non‐parenchymal cells within the regenerative niche. We also outline promising translational strategies, including molecular‐targeted therapy, cell‐based therapy, liver tissue engineering, and nanocarrier delivery systems. This review links basic mechanistic findings to clinical translation, discusses key existing research challenges, and offers useful insights for developing precision therapeutics for liver regeneration.

Read PDF

Similar papers

Review Open access Sep 2026

Effects and Therapeutic Strategies of Intra-Hepatic Cellular Senescence and Regeneration

The liver constitutes a vital organ characterized by remarkable regenerative capacity, wherein intra-hepatic cellular senescence and regeneration exert pivotal regulatory functions in maintaining hepatic homeostasis and in developing therapeutic interventions for liver diseases. Intra-hepatic cellular aging is typicall...

Jing Yang, Yuan-Heng Li, Yi-Xuan Feng et al. · 0 citations
Review Oct 2026

Pathophysiology and Pharmacological Management of Chronic Liver Injury: Current Challenges and Future Directions.

INTRODUCTION Chronic liver injury results from persistent hepatic injuries such as metabolic disorders, alcohol consumption, viral infections, drug toxicity, autoimmune conditions, and genetic factors. It is a major global health concern due to its progression to fibrosis, cirrhosis, and hepatocellular carcinoma. This...

Naziya Parveen, Mayank Kumar, Monojit Das et al. · 0 citations
Review Open access Oct 2026

Pathophysiological mechanisms and therapeutic strategies of hepatic ischemia–reperfusion injury

Hepatic ischemia–reperfusion injury commonly occurs in conditions such as trauma, shock, hepatectomy, and liver transplantation. In the absence of timely intervention, severe cases may progress to liver failure, significantly affecting patient prognosis and surgical outcomes. Therefore, a comprehensive understanding...

Si-Yu Hou, Man-Man Xu, Chun-Zeng Jia et al. · 0 citations
Open access Oct 2026

Phospholipid phosphatase 2 drives liver repair and regeneration after acute liver injury

Acute liver injury is commonly caused by overdose-drug, toxins, or ischemia. The liver possesses a remarkable regenerative capacity, wherein metabolic remodeling plays a crucial role in restoring hepatic function and homeostasis. However, the specific metabolic shift that initiates hepatocyte regeneration remains uncle...

Fan Li, Yi-Ming Wang, Peng-Yao Chen et al. · 0 citations
Review Oct 2026

Hepatic Ischemia-Reperfusion Injury in Liver Transplantation: Molecular Mechanisms.

BACKGROUND Hepatic ischemia-reperfusion injury (HIRI) remains a major determinant of graft dysfunction and adverse outcomes in liver transplantation, particularly in the context of extended criteria donors. The complex interplay between metabolic disruption, oxidative stress, endothelial dysfunction, and immune activat...

Eduardo E. Montalvo-Javé, N. Nuño-Lámbarri, T. Pawlik et al. · 0 citations
Review Oct 2026

Emerging nanomedicine upshot: Reprogramming cellular dormancy for tissue regeneration.

Trends in regenerative medicine are transforming the field by moving beyond simple repair to actively reprogram cellular and tissue environments. This review explores new approaches that integrate nanotechnology, metabolic regulation, and immune engineering to improve the regeneration of tissues that are otherwise diff...

Tiya Rawat, Nida Irfan Pathan, Devyani Sengar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.